FBR initiates coverage on numerous healthcare names


Alkermes (ALKS) started at Market Perform. Price target is $31.

Sarepta Therapeutics (SRPT) started at Market Perform. Price target is $48.

Regulus Therapeutics (RGLS) started at Outperform. Price target is $15.

Forest Labs (FRX) started at Market Perform. Price target is $48.

Supernus Pharmaceuticals (SUPN) started at Outperform. Price target is $12.

Raptor Pharmaceuticals (RPTP) started at Outperform. Price target is $17.

Kythera Biopharmaceuticals (KYTH) started at Outperform. Price target is $58.

Endo Pharmaceuticals (ENDP) started at Market Perform. Price target is $40.

Valeant Pharmaceuticals (VRX) started at Outperform. Price target is $130.

Aegerion Pharmaceuticals (AEGR) started at Outperform. Price target is $105.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs